Findings from the Section on Bioinformatics and Translational Informatics

Summary

Objectives: To summarize excellent current research and propose a selection of best papers published in 2016 in the field of Bioinformatics and Translational Informatics with applications in the health domain and clinical care.

Method: We provide a synopsis of the articles selected for the IMIA Yearbook 2017, from which we attempt to derive a synthetic overview of current and future activities in the field. As in 2016, a first step of selection was performed by querying MEDLINE with a list of MeSH descriptors completed by a list of terms adapted to the section coverage. Each section editor evaluated separately the set of 951 articles returned and evaluation results were merged for retaining 15 candidate best papers for peer-review.

Results: The selection and evaluation process of papers published in the Bioinformatics and Translational Informatics field yielded four excellent articles focusing this year on the secondary use and massive integration of multi-omics data for cancer genomics and non-cancer complex diseases. Papers present methods to study the functional impact of genetic variations, either at the level of the transcription or at the levels of pathway and network.

Conclusions: Current research activities in Bioinformatics and Translational Informatics with applications in the health domain continue to explore new algorithms and statistical models to manage, integrate, and interpret large-scale genomic datasets. As addressed by some of the selected papers, future trends would include the question of the international collaborative sharing of clinical and omics data, and the implementation of intelligent systems to enhance routine medical genomics.

Keywords

Translational medical research - computational biology - gene genome expression - genome - medical informatics

• References

• 1 Dauchel H, Lecroq T. Findings from the Section on Bioinformatics and Translational Informatics. Yearb Med Inform 2016; 207-10.
• 2 1000 Genomes Project Consortium. Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO. et al. A global reference for human genetic variation. Nature 2015; 526 (7571): 68-74.
• 3 Edwards NJ, Oberti M, Thangudu RR, Cai S, Mc-Garvey PB, Jacob S. et al. The CPTAC Data Portal: A Resource for Cancer Proteomics Research. J Proteome Res 2015; 14 (06) 2707-13.
• 4 Lamy J-B, Séroussi B, Griffon N, Kerdelhué G, Jaulent M-C, Bouaud J. Toward a formalization of the process to select IMIA Yearbook best papers. Methods Inf Med 54 (02) 2015; 135-44.
• 5 Ammenwerth E, Wolff AC, Knaup P, Ulmer H, Skonetzki S, van Bemmel JH. et al. Developing and evaluating criteria to help reviewers of biomedical informatics manuscripts. J Am Med Inform Assoc 2003; 10 (05) 512-4.
• 6 Chen J, Rozowsky J, Galeev TR, Harmanci A, Kitchen R, Bedford J. et al. A uniform survey of allele-specific binding and expression over 1000-Genomes-Project individuals. Nat Commun 2016; 07: 11101.
• 7 Marbach D, Lamparter D, Quon G, Kellis M, Kutalik Z, Bergmann S. Tissue-specific regulatory circuits reveal variable modular perturbations across complex diseases. Nat Methods 2016; 13 (04) 366-70.
• 8 Zhang D, Chen P, Zheng CH, Xia J. Identification of ovarian cancer subtype-specific network modules and candidate drivers through an integrative genomics approach. Oncotarget 2016; 07 (04) 4298-309.
• 9 Zhang J, White NM, Schmidt HK, Fulton RS, Tomlinson C, Warren WC. et al. INTEGRATE: gene fusion discovery using whole genome and transcriptome data. Genome Res 2016; 26 (01) 108-18.
• 10 Chu A, Robertson G, Brooks D, Mungall AJ, Birol I, Coope R. et al. Large-scale profiling of microR-NAs for The Cancer Genome Atlas. Nucleic Acids Res 2016; 44 (01) e3.
• 11 Williams MJ, Werner B, Barnes CP, Graham TA, Sottoriva A. Identification of neutral tumor evolution across cancer types. Nat Genet 2016; 48 (03) 238-44.
• 12 Yang Z, Michailidis G. A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data. Bioinfor-matics 2016; 32 (01) 1-8.
• 13 Rudnick PA, Markey SP, Roth J, Mirokhin Y, Yan X, Tchekhovskoi DV. et al. A Description of the Clinical Proteomic Tumor Analysis Consortium (CPTAC) Common Data Analysis Pipeline. J Proteome Res 2016; 15 (03) 1023-32.
• 14 Mertins P, Mani DR, Ruggles KV, Gillette MA, Clauser KR, Wang P. et al. Proteogenomics connects somatic mutations to signaling in breast cancer. Nature 2016; 534 (7605): 55-62.
• 15 Şenbabaoğlu Y, Sümer SO, Sánchez-Vega F, Bemis D, Ciriello G N, Schultz N. et al A Multi-Method Approach for Proteomic Network Inference in 11 Human Cancers. PLoS Comput Biol 2016; 12 (02) e1004765.
• 16 Zhao J, Cheng F, Wang Y, Arteaga CL, Zhao Z. Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based Approach. Mol Cell Proteomics 2016; 15 (02) 642-56.
• 17 Lu Q, Yao X, Hu Y, Zhao H. GenoWAP: GWAS signal prioritization through integrated analysis of genomic functional annotation. Bioinformatics 2016; 32 (04) 542-8.
• 18 Li JR, Sun CH, Li W, Chao RF, Huang CC, Zhou XJ. et al. Cancer RNA-Seq Nexus: a database of phenotype-specific transcriptome profiling in cancer cells. Nucleic Acids Res 2016; 44 (D1): D944-D951.
• 19 Weitzel KW, Alexander M, Bernhardt BA, Calman N, Carey DJ, Cavallari LH. et al. The IGNITE network: a model for genomic medicine implementation and research. BMC Med Genomics 2016; 09: 1.
• 20 Global Alliance for Genomics and Health. GENOMICS. A federated ecosystem for sharing genomic, clinical data. Science 2016; 352 (6291): 1278-80.